A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response

REFERENCES

• Allen BL, Taatjes DJ. 2015. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol 16:155–166. https://doi.org/10.1038/nrm3951.
   PubMed Web of Science ®Google Scholar
• Daniels DL, Ford M, Schwinn MK, Benink H, Galbraith MD, Amunugama R, Jones R, Allen D, Okazaki N, Yamakawa H, Miki F, Nagase T, Espinosa JM, Urh M. 2013. Mutual exclusivity of MED12/MED12L, MED13/13L, and CDK8/19 paralogs revealed within the CDK-Mediator kinase module. J Proteomics Bioinform S2:004.
   Google Scholar
• Galbraith MD, Allen MA, Bensard CL, Wang X, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD, Espinosa JM. 2013. HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell 153:1327–1339. https://doi.org/10.1016/j.cell.2013.04.048.
   PubMed Web of Science ®Google Scholar
• Kagey M, Newman J, Bilodeau S, Zhan Y, Van Berkum N, Orlando DA, Ebmeier CC, Goossens J, Rahl P, Levine S, Taatjes DJ, Dekker J, Young RA. 2010. Mediator and Cohesin connect gene expression and chromatin architecture. Nature 467:430–435. https://doi.org/10.1038/nature09380.
   PubMed Web of Science ®Google Scholar
• Pelish HE, Liau BB, Nitulescu II, Tangpeerachaikul A, Poss ZC, Da Silva DH, Caruso BT, Arefolov A, Fadeyi O, Christie AL, Du K, Banka D, Schneider EV, Jestel A, Zou G, Si C, Ebmeier CC, Bronson RT, Krivtsov AV, Myers AG, Kohl NE, Kung AL, Armstrong SA, Lemieux ME, Taatjes DJ, Shair MD. 2015. Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature 526:273–276. https://doi.org/10.1038/nature14904.
   PubMed Web of Science ®Google Scholar
• Phillips-Cremins JE, Sauria ME, Sanyal A, Gerasimova TI, Lajoie BR, Bell JS, Ong CT, Hookway TA, Guo C, Sun Y, Bland MJ, Wagstaff W, Dalton S, McDevitt TC, Sen R, Dekker J, Taylor J, Corces VG. 2013. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153:1281–1295. https://doi.org/10.1016/j.cell.2013.04.053.
   PubMed Web of Science ®Google Scholar
• Davis MA, Larimore EA, Fissel BM, Swanger J, Taatjes DJ, Clurman BE. 2013. The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator. Genes Dev 27:151–156. https://doi.org/10.1101/gad.207720.112.
   PubMed Web of Science ®Google Scholar
• Mo X, Kowenz-Leutz E, Xu H, Leutz A. 2004. Ras induces mediator complex exchange on C/EBPb. Mol Cell 13:241–250. https://doi.org/10.1016/S1097-2765(03)00521-5.
   PubMed Web of Science ®Google Scholar
• Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, Tempst P, de Murcia G, Evans R, Chambon P, Reinberg D. 2005. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 18:83–96. https://doi.org/10.1016/j.molcel.2005.02.034.
   PubMed Web of Science ®Google Scholar
• Taatjes DJ, Naar AM, Andel F, Nogales E, Tjian R. 2002. Structure, function, and activator-induced conformations of the CRSP coactivator. Science 295:1058–1062. https://doi.org/10.1126/science.1065249.
   PubMed Web of Science ®Google Scholar
• Bernecky C, Grob P, Ebmeier CC, Nogales E, Taatjes DJ. 2011. Molecular architecture of the human Mediator-RNA polymerase II-TFIIF assembly. PLoS Biol 9:e1000603. https://doi.org/10.1371/journal.pbio.1000603.
   PubMed Web of Science ®Google Scholar
• Plaschka C, Lariviere L, Wenzeck L, Seizl M, Hemann M, Tegunov D, Petrotchenko EV, Borchers CH, Baumeister W, Herzog F, Villa E, Cramer P. 2015. Architecture of the RNA polymerase II-Mediator core initiation complex. Nature 518:376–380. https://doi.org/10.1038/nature14229.
   PubMed Web of Science ®Google Scholar
• Robinson PJ, Trnka MJ, Bushnell DA, Davis RE, Mattei PJ, Burlingame AL, Kornberg RD. 2016. Structure of a complete mediator-RNA polymerase II pre-initiation complex. Cell 166:1411–1422. https://doi.org/10.1016/j.cell.2016.08.050.
   PubMed Web of Science ®Google Scholar
• Tsai KL, Yu X, Gopalan S, Chao TC, Zhang Y, Florens L, Washburn MP, Murakami K, Conaway RC, Conaway JW, Asturias FJ. 2017. Mediator structure and rearrangements required for holoenzyme formation. Nature 544:196–201. https://doi.org/10.1038/nature21393.
   PubMed Web of Science ®Google Scholar
• Elmlund H, Baraznenok V, Lindahl M, Samuelsen CO, Koeck PJB, Holmberg S, Hebert H, Gustafsson CM. 2006. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc Natl Acad Sci U S A 103:15788–15793. https://doi.org/10.1073/pnas.0607483103.
   PubMed Web of Science ®Google Scholar
• Knuesel MT, Meyer KD, Bernecky C, Taatjes DJ. 2009. The human CDK8 subcomplex is a molecular switch that controls Mediator co-activator function. Genes Dev 23:439–451. https://doi.org/10.1101/gad.1767009.
   PubMed Web of Science ®Google Scholar
• Tsai KL, Sato S, Tomomori-Sato C, Conaway RC, Conaway JW, Asturias FJ. 2013. A conserved Mediator-CDK8 kinase module association regulates Mediator-RNA polymerase II interaction. Nat Struct Mol Biol 20:611–619. https://doi.org/10.1038/nsmb.2549.
   PubMed Web of Science ®Google Scholar
• Ebmeier CC, Taatjes DJ. 2010. Activator-Mediator binding regulates Mediator-cofactor interactions. Proc Natl Acad Sci U S A 107:11283–11288. https://doi.org/10.1073/pnas.0914215107.
   PubMed Web of Science ®Google Scholar
• Naar AM, Taatjes DJ, Zhai W, Nogales E, Tjian R. 2002. Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation. Genes Dev 16:1339–1344. https://doi.org/10.1101/gad.987602.
   PubMed Web of Science ®Google Scholar
• Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM. 2010. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol 17:194–201. https://doi.org/10.1038/nsmb.1752.
   PubMed Web of Science ®Google Scholar
• Perez-Perri JI, Dengler VL, Audetat KA, Pandey A, Bonner EA, Urh M, Mendez J, Daniels DL, Wappner P, Galbraith MD, Espinosa JM. 2016. The TIP60 complex is a conserved coactivator of HIF1A. Cell Rep 16:37–47. https://doi.org/10.1016/j.celrep.2016.05.082.
   PubMed Web of Science ®Google Scholar
• Bancerek J, Poss ZC, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I, Dolken L, Strobl B, Muller M, Taatjes DJ, Kovarik P. 2013. CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity 38:250–262. https://doi.org/10.1016/j.immuni.2012.10.017.
   PubMed Web of Science ®Google Scholar
• Dale T, Clarke PA, Esdar C, Waalboer D, Adeniji-Popoola O, Ortiz-Ruiz MJ, Mallinger A, Samant RS, Czodrowski P, Musil D, Schwarz D, Schneider K, Stubbs M, Ewan K, Fraser E, TePoele R, Court W, Box G, Valenti M, de Haven Brandon A, Gowan S, Rohdich F, Raynaud F, Schneider R, Poeschke O, Blaukat A, Workman P, Schiemann K, Eccles SA, Wienke D, Blagg J. 2015. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol 11:973–980. https://doi.org/10.1038/nchembio.1952.
   PubMed Web of Science ®Google Scholar
• Fryer CJ, White JB, Jones KA. 2004. Mastermind recruits CycC:Cdk8 to phosphorylate the notch ICD and coordinate activation with turnover. Mol Cell 16:509–520. https://doi.org/10.1016/j.molcel.2004.10.014.
   PubMed Web of Science ®Google Scholar
• Xu D, Li CF, Zhang X, Gong Z, Chan CH, Lee SW, Jin G, Rezaeian AH, Han F, Wang J, Yang WL, Feng ZZ, Chen W, Wu CY, Wang YJ, Chow LP, Zhu XF, Zeng YX, Lin HK. 2015. Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis. Nat Commun 6:6641. https://doi.org/10.1038/ncomms7641.
   PubMed Web of Science ®Google Scholar
• Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, Macdonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morrissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA, Garraway LA. 2012. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44:685–689. https://doi.org/10.1038/ng.2279.
   PubMed Web of Science ®Google Scholar
• Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC. 2008. CDK8 is a colorectal cancer oncogene that regulates b-catenin activity. Nature 455:547–551. https://doi.org/10.1038/nature07179.
   PubMed Web of Science ®Google Scholar
• Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, Polsky D, Osman I, Garcia BA, Hernando E, Bernstein E. 2010. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468:1105–1109. https://doi.org/10.1038/nature09590.
   PubMed Web of Science ®Google Scholar
• Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour MR, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, Bury L, Meyer CA, Ke N, Mulry KA, Kluk MJ, Roy M, Kim S, Zhang X, Geng Y, Zagozdzon A, Jenkinson S, Gale RE, Linch DC, Zhao JJ, Mullighan CG, Harper JW, Aster JC, Aifantis I, von Boehmer H, Gygi SP, Wei W, Look AT, Sicinski P. 2014. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol 16:1080–1091. https://doi.org/10.1038/ncb3046.
   PubMed Web of Science ®Google Scholar
• Makinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, Aavikko M, Katainen R, Virolainen E, Bohling T, Koski TA, Launonen V, Sjoberg J, Taipale J, Vahteristo P, Aaltonen LA. 2011. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334:252–255. https://doi.org/10.1126/science.1208930.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay A, Kramer JM, Merkx G, Lugtenberg D, Smeets DF, Oortveld MAW, Blokland EAW, Agrawal J, Schenck A, van Bokhoven H, Huys E, Schoenmakers EF, van Kessel AG, van Nouhuys CE, Cremers FPM. 2010. CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation. Hum Genet 128:281–291. https://doi.org/10.1007/s00439-010-0848-x.
   PubMed Web of Science ®Google Scholar
• Muncke N, Jung C, Rudiger H, Ulmer H, Roeth R, Hubert A, Goldmuntz E, Driscoll D, Goodship J, Schon K, Rappold G. 2003. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 108:2843–2850. https://doi.org/10.1161/01.CIR.0000103684.77636.CD.
   PubMed Web of Science ®Google Scholar
• Risheg H, Graham JM, Clark RD, Rogers RC, Opitz JM, Moeschler JB, Peiffer AP, May M, Joseph SM, Jones JR, Stevenson RE, Schwartz CE, Friez MJ. 2007. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat Genet 39:451–453. https://doi.org/10.1038/ng1992.
   PubMed Web of Science ®Google Scholar
• Utami KH, Winata CL, Hillmer AM, Aksoy I, Long HT, Liany H, Chew EG, Mathavan S, Tay SK, Korzh V, Sarda P, Davila S, Cacheux V. 2014. Impaired development of neural-crest cell-derived organs and intellectual disability caused by MED13L haploinsufficiency. Hum Mutat 35:1311–1320. https://doi.org/10.1002/humu.22636.
   PubMed Web of Science ®Google Scholar
• Kuchin S, Yeghiayan P, Carlson M. 1995. Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. Proc Natl Acad Sci U S A 92:4006–4010. https://doi.org/10.1073/pnas.92.9.4006.
   PubMed Web of Science ®Google Scholar
• Mousley CJ, Yuan P, Gaur NA, Trettin KD, Nile AH, Deminoff SJ, Dewar BJ, Wolpert M, Macdonald JM, Herman PK, Hinnebusch AG, Bankaitis VA. 2012. A sterol-binding protein integrates endosomal lipid metabolism with TOR signaling and nitrogen sensing. Cell 148:702–715. https://doi.org/10.1016/j.cell.2011.12.026.
   PubMed Web of Science ®Google Scholar
• Chi Y, Huddleston MJ, Zhang X, Young RA, Annan RS, Carr SA, Deshaies RA. 2001. Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev 15:1078–1092. https://doi.org/10.1101/gad.867501.
   PubMed Web of Science ®Google Scholar
• Hirst M, Kobor MS, Kuriakose N, Greenblatt J, Sadowski I. 1999. GAL4 is regulated by the RNA polymerase II holoenzyme-associated cyclin-dependent protein kinase SRB10/CDK8. Mol Cell 3:673–678. https://doi.org/10.1016/S1097-2765(00)80360-3.
   PubMed Web of Science ®Google Scholar
• Holstege FC, Jennings EG, Wyrick JJ, Lee TI, Hengartner CJ, Green MR, Golub TR, Lander ES, Young RA. 1998. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95:717–728. https://doi.org/10.1016/S0092-8674(00)81641-4.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. https://doi.org/10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Pohl MO, Zhou Y, Rodriguez-Frandsen A, Wang G, Stein DA, Moulton HM, DeJesus P, Che J, Mulder LC, Yanguez E, Andenmatten D, Pache L, Manicassamy B, Albrecht RA, Gonzalez MG, Nguyen Q, Brass A, Elledge S, White M, Shapira S, Hacohen N, Karlas A, Meyer TF, Shales M, Gatorano A, Johnson JR, Jang G, Johnson T, Verschueren E, Sanders D, Krogan N, Shaw M, Konig R, Stertz S, Garcia-Sastre A, Chanda SK. 2015. Meta- and orthogonal integration of influenza “OMICs” data defines a role for UBR4 in virus budding. Cell Host Microbe 18:723–735. https://doi.org/10.1016/j.chom.2015.11.002.
   PubMed Web of Science ®Google Scholar
• Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. 2004. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844–848. https://doi.org/10.1126/science.1092472.
   PubMed Web of Science ®Google Scholar
• Momand J, Jung D, Wilczynski S, Niland J. 1998. The MDM2 gene amplification database. Nucleic Acids Res 26:3453–3459. https://doi.org/10.1093/nar/26.15.3453.
   PubMed Web of Science ®Google Scholar
• Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Borresen-Dale AL, Levine AJ, Bargonetti J, Prives C. 2012. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148:244–258. https://doi.org/10.1016/j.cell.2011.12.017.
   PubMed Web of Science ®Google Scholar
• Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, Parker M, Rusch M, Nagahawatte P, Wu J, Mao S, Boggs K, Mulder H, Yergeau D, Lu C, Ding L, Edmonson M, Qu C, Wang J, Li Y, Navid F, Daw NC, Mardis ER, Wilson RK, Downing JR, Zhang J, Dyer MA, St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. 2014. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7:104–112. https://doi.org/10.1016/j.celrep.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, Helman E, Taylor-Weiner A, McKenna A, DeLuca DS, Lawrence MS, Ambrogio L, Sougnez C, Sivachenko A, Walensky LD, Wagle N, Mora J, de Torres C, Lavarino C, Dos Santos Aguiar S, Yunes JA, Brandalise SR, Mercado-Celis GE, Melendez-Zajgla J, Cardenas-Cardos R, Velasco-Hidalgo L, Roberts CW, Garraway LA, Rodriguez-Galindo C, Gabriel SB, Lander ES, Golub TR, Orkin SH, Getz G, Janeway KA. 2014. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A 111:E5564–E5573. https://doi.org/10.1073/pnas.1419260111.
   PubMed Web of Science ®Google Scholar
• Ohata N, Ito S, Yoshida A, Kunisada T, Numoto K, Jitsumori Y, Kanzaki H, Ozaki T, Shimizu K, Ouchida M. 2006. Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma. Int J Mol Med 18:1153–1158.
   PubMed Web of Science ®Google Scholar
• Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y, Yang ES, Liu LP, Vaitheesvaran B, Bridges L, Kurland IJ, Strich R, Ni JQ, Wang C, Ericsson J, Pessin JE, Ji JY, Yang F. 2012. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 122:2417–2427. https://doi.org/10.1172/JCI61462.
   PubMed Web of Science ®Google Scholar
• Poss ZC, Ebmeier CC, Odell AT, Tangpeerachaikul A, Lee T, Pelish HE, Shair MD, Dowell RD, Old WM, Taatjes DJ. 2016. Identification of mediator kinase substrates in human cells using cortistatin A and quantitative phosphoproteomics. Cell Rep 15:436–450. https://doi.org/10.1016/j.celrep.2016.03.030.
   PubMed Web of Science ®Google Scholar
• Bu P, Evrard YA, Lozano G, Dent SY. 2007. Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol Cell Biol 27:3405–3416. https://doi.org/10.1128/MCB.00066-07.
   PubMed Web of Science ®Google Scholar
• Hagelkruys A, Mattes K, Moos V, Rennmayr M, Ringbauer M, Sawicka A, Seiser C. 2015. Essential nonredundant function of the catalytic activity of histone deacetylase 2 in mouse development. Mol Cell Biol 36:462–474. https://doi.org/10.1128/MCB.00639-15.
   PubMedGoogle Scholar
• Donner AJ, Szostek S, Hoover JM, Espinosa JM. 2007. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 27:121–133. https://doi.org/10.1016/j.molcel.2007.05.026.
   PubMed Web of Science ®Google Scholar
• Isakoff MS, Bielack SS, Meltzer P, Gorlick R. 2015. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol 33:3029–3035. https://doi.org/10.1200/JCO.2014.59.4895.
   PubMed Web of Science ®Google Scholar
• Sullivan KD, Padilla-Just N, Henry RE, Porter CC, Kim J, Tentler JJ, Eckhardt SG, Tan AC, DeGregori J, Espinosa JM. 2012. ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53. Nat Chem Biol 8:646–654. https://doi.org/10.1038/nchembio.965.
   PubMedGoogle Scholar
• Anders S, Pyl PT, Huber W. 2015. HTSeq: a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166–169. https://doi.org/10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 15:550. https://doi.org/10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, Delmonte T, Villeneuve A, Sladek R, Xu F, Mitchell GA, Morin C, Mann M, Hudson TJ, Robinson B, Rioux JD, Lander ES. 2003. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 100:605–610. https://doi.org/10.1073/pnas.242716699.
   PubMed Web of Science ®Google Scholar
• Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. 2006. GenePattern 2.0. Nat Genet 38:500–501. https://doi.org/10.1038/ng0506-500.
   PubMed Web of Science ®Google Scholar
• Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM. 2006. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev 20:601–612. https://doi.org/10.1101/gad.1398206.
   PubMed Web of Science ®Google Scholar